AYURVEDIC AND MODERN ASPECTS OF SUDARSHAN (CRINUM LATIFOLIUM LINN): AN OVERVIEW
Abstract
Sudarshana (Crinum Latifolium Linn) belongs to family Amaryllidaceae has a great importance due to its medicinal properties and for ornamental values found to be useful in plantation in homes, gardens etc. It produces beautiful white flower. Leaves also marked for its ornamental purpose. This plants mature mother bulb producing several new small adventitious bulbs around its body and are significantly used to propagate by vegetative modes. Sudarshana (Crinum Latifolium Linn) possess predominant Madhur tikta rasa, Ushna veerya and Madhur vipak. In Ayurveda Sudarshan is commonly used as a Kushtaghna (Useful in skin diseases), jvraghna (anti pyretic), shodhahara (anti-inflammatory), Krumighna (to kill warms).The useful part of Sudarshana is leaf and rhizome. The main chemical constituents of Crinum latifolium the rhizome of the plant contains Glucans Alkoloids-zeylamine crinofoline,crinofolidine,tazetine,flexinine,harmenthamine,ambelline, galanthamine.The leaves contain alkaloids latifine, cherilline, 3-0-acetalamine, crinomine and crinine. The plant includes much medicinal property and is used in multifold directions/purpose to treat varied disorders such as anti-oxidant, Anti-microbial, Anthelmintic. This rivew give detail information regarding Crinum Latifolium Linn. The present review article provides up-to-date information on the medicinal properties of the plant.
KEYWORDS: Crinum, Ornamental, Sudarshana, Amaryllidaceae, JvraghnaReferences
Dravyaguna-Vijnana, Vol.II, Vegetable Drugs, by Prof. P. V. Sharma, Reprint, Chaukhambha Bharati Academy, Varanasi, 2006; 233-234.
Crenum latifolium nata http://en.wikipedia.org/wiki Crenum latifolium, 2020; 11: 2.
Sharma P, Dayal R, Ayyer KS. Chemical constituents of Crinum latifolium Linn. Indian Journal of Chemical Society, 1999; 60.
Benson L: Plant Classification. Oxford and I.B.H publishing Co., New Delhi, Bombay, 1970: 793-797.
Mabberly DJ: The plant book. Cambridge University Press, 1990.
Fennell CW and Van Staden J: Crinum species in traditional and modern medicine. Journal of Ethnopharmacology 2001; 78(1):15– 26.
Crinum latifolium: http://www. rain-tree.com/cormama./tropical plant database, 2020; 15: 02.
Bhavprakash nighantu, Dr.G.S Pandy, Chaukhamba bharti academy, Varanasi, 2013.
Pandit.Hariprasad Tripathi, Madanpal Nighantu (Hindi translation) 1st edition Varanasi; Chaukhamba Krishnadas academy; ( 2009).
Sharma, P. V; Kaidev Nighantu; 1st Edition; 1979; Chowkhamba Oriental; Varanasi, Delhi.
Vaidya Bapala, G. I; Nighantu Adarsha; 1st Edition; 1968; Chowkhamba Vidyabhavan; Varanasi; Uttarardha. 12.
Nandkaran K.M The Indian Materia Medica, Bombay Popular Prakashan, Mumbai, 1954; 1(1): 209-213.
Kirtikar KR, Basu BD “Indian Medicinal Plants”, International Book Distributor, Dehradun, 2005; 190: 230.
Dravyaguna-Vijnana, Vol.II, Vegetable Drugs, by Prof. P.V. Sharma, Reprint: 2006, Chaukhambha Bharati Academy, Varanasi.
Ghosal S, Saini KS, Frahm AW Alkaloids of Crinum latifolium. Phytochem, 1983; 22: 2305-2309.
6. Ghosal S, Saini KS, Razdan S Crinum alkaloids: their chemistry and biology. Phytochem, 1985; 24: 2141-2156.
Liao H, Banbury LK, Leach DN. Antioxidant activity of 45 Chinese herbs and the relationship with their TCM characteristics. Evid Based Complement Alternat Med. 2008; 4: 429–434. doi:10.1093/ecam/nem054
Nam NH and Jae YY: NF-κB Inhibitory activities of the methanol extracts and some constituents therein of some Vietnamese medicinal plants. Scientia Pharmaceutica 2009; 77:389–399.
29. Jenny M, Wondrak A, Zvetkova E, Tram NT, Phi PT, Schennach H, Culig Z, Ueberall F and Fuchs D: Crinum latifolium leave extracts suppress immune activation cascades in peripheral blood mononuclear cells and proliferation of prostate tumor cells. Scientia Pharmaceutica 2011 79:323–335.
Wildman WC: The Alkaloids: Chemistry and Physiology. Edited by R.H.F. Manske, Academic Press, New York, London, Vol. VI, 1960.
Harvey AL: The pharmacology of galanthamine and its analogues. Pharmacology and Therapeutics 1995; 68(1):113–128.
Greenblatt HM, Kryger G, Lewis T, Silman I and Sussman J: Structure of acetylcholinestrase complexed with (–)-galanthamine at 2.3 Å resolution. FEBS Lett 1999; 463:321–326.
37. Lewis JR: Amaryllidaceae and Sceletium alkaloids. Natural Products Reports 1998; 15:107–110.
Sener B and Orhan I: Discovery of drug candidates from some Turkish plants and conservation of biodiversity. Pure and Applied Chemistry 2005; 77(1):53–64.
Cozanitis DA and Toivakka E: A comparative study of galanthamine HBr and atropine/neostigmine in conscious volunteers. Anaesthesist 1971; 20:416–421.
Reimann D, Gann H, Dressing H, Müller WE and Aldenhoff JB: Influence of the cholinesterase inhibitor galanthamine HBr on normal sleep. Psychiatry Research 1994; 51:253–267.
Zvetkova E, Wirleitner B, Tram N, Schennach H and Fuchs D: Aqueous extracts of Crinum latifolium L. and Camellia sinensis show immunomodulatory properties in human peripheral blood mononuclear cells. Journal of International Immunopharmacology 2001; 1(12): 2143–2150.
Tram NT, Zvetkova E, Nikolova E, Katzarova E, Kostov G, Yanchev I and Baicheva O: A novel in vitro and in vivo Tlymphocyte activating factor in Crinum latifolium L. aqueous extracts. Experimental Pathology and Parasitology 1999; 3:21–26.
Tram N, Yanchev I, Zvetkova E, Dineva J, Katzarova E, Kostov G, Svilenov D, Ilieva I and Shalamanov P: Retarded growth of chemically induced with 20-methylcholanthrene tumours in rats under the action of cold-hot aqueous extracts (decoctions) from Vietnamese plant Crinum latifolium (L.). Experimental Pathology and Parasitology 2001; 4(7):9–12.
Levin S: Traditional Vietnamese herb Crinum latifolium shows promise for prostate and ovarian health. International Journal of Immunopharmacology 2001; 1(12): 2143-2150.
Jenny M, Wondrak A, Zvetkova E, Tram NT, Phi PT, Schennach H, Culig Z, Ueberall F and Fuchs D: Crinum latifolium leave extracts suppress immune activation cascades in peripheral blood mononuclear cells and proliferation of prostate tumor cells. Scientia Pharmaceutica 2011 79:323–335.
